No CPD Points                                                        

Course Summary

Professor Steve Taylor & Mark Nevin (15:19)

Fluorescein dye, an established aid routinely used by eye care practitioners, has recently become subject to controversy. Confusion over its classification and the withdrawal of fluorescein impregnated strips, Fluorets, from the market have led to concerns over legality and appropriate use.

In light of this, the Optical Confederation Clinical Consensus Panel and, more recently, the MHRA have provided clarification. Here, two members of the Clinical Consensus Panel; Professor Steve Taylor, a fellow of the College of Optometrists and professional advisor to FODO, and Mark Nevin, director of policy and strategy at FODO, the FMO and ACLM, discuss the issue further.

First published in DOCET OQ89 (2014).

    Open all

    Instructions: Clicking on the section name will show / hide the section.

    View only 'Topic 1'

    6.1.4 To understand the current use of diagnostic dyes for UK optometrists and how CE marked agents are classified and what limits there are on their use.

      View only 'Topic 2'
      View only 'Topic 3'


      • FODO. 2013. Clinical consensus panel report on the use of fluorescein in primary care. Sept 2013.
      • Optical Confederation. 2013. Update on the use of fluorescein strips. 25 June 2013.
      • Morgan PB, Maldonado-Codina C. 2009. Corneal staining: Do we really understand what we are seeing? Cont Lens Anterior Eye 32 (2), 48 – 54.
      • MRHA. 2013. Medicines regulatory news: The regulatory position on fluorescein strips. 30 December 2013.
      • Peterson RC, Wolffsohn JS, Fowler CW. 2006. Optimisation of anterior eye fluorescein viewing. American Journal of Ophthalmology 142, 572 – 5.
      • Shahid H, Salmon J. 2010. Anaphylactic response to topical fluorescein 2% eye drops: A case report. J Med Case Reports 4, 27.
        View only 'Topic 4'

        Please give your feedback on this course. Click on the link below to launch the evaluation form.